Novartis AG (NVSEF)
134.53
+0.33
(+0.25%)
USD |
OTCM |
Oct 05, 16:00
Novartis Profit Margin (Quarterly) : 22.61% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.61% |
| March 31, 2026 | 24.07% |
| December 31, 2025 | 18.03% |
| September 30, 2025 | 28.26% |
| June 30, 2025 | 28.63% |
| March 31, 2025 | 27.27% |
| December 31, 2024 | 21.44% |
| September 30, 2024 | 24.84% |
| June 30, 2024 | 25.94% |
| March 31, 2024 | 22.72% |
| December 31, 2023 | 23.09% |
| September 30, 2023 | 12.84% |
| June 30, 2023 | 19.86% |
| March 31, 2023 | 19.91% |
| December 31, 2022 | 12.43% |
| September 30, 2022 | 12.68% |
| June 30, 2022 | 13.26% |
| March 31, 2022 | 17.71% |
| December 31, 2021 | |
| September 30, 2021 | 21.17% |
| June 30, 2021 | 22.34% |
| March 31, 2021 | 16.59% |
| December 31, 2020 | 16.44% |
| September 30, 2020 | 15.76% |
| June 30, 2020 | 16.45% |
| Date | Value |
|---|---|
| March 31, 2020 | 17.69% |
| December 31, 2019 | 9.10% |
| September 30, 2019 | 16.77% |
| June 30, 2019 | 17.93% |
| March 31, 2019 | 16.74% |
| December 31, 2018 | 10.61% |
| September 30, 2018 | 17.04% |
| June 30, 2018 | 68.03% |
| March 31, 2018 | 18.03% |
| December 31, 2017 | 15.30% |
| September 30, 2017 | 16.78% |
| June 30, 2017 | 16.17% |
| March 31, 2017 | 14.43% |
| December 31, 2016 | 7.60% |
| September 30, 2016 | 16.04% |
| June 30, 2016 | 14.48% |
| March 31, 2016 | 17.34% |
| December 31, 2015 | 8.42% |
| September 30, 2015 | 14.77% |
| June 30, 2015 | 14.62% |
| March 31, 2015 | 19.28% |
| December 31, 2014 | 18.64% |
| September 30, 2014 | 23.78% |
| June 30, 2014 | 20.30% |
| March 31, 2014 | 21.17% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Addex Therapeutics Ltd. | -17.52K% |
| Oculis Holding AG | -- |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 29.75% |
| Return on Assets | 11.22% |
| Return on Invested Capital | 15.53% |
| Gross Profit Margin (Quarterly) | 74.47% |
| Operating Margin (Quarterly) | 32.84% |
| Return on Net Operating Assets | 14.50% |